<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSM28849"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM28849"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM28849"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM28850"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM28850"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM28850"><item key="disease state">colon cancer</item><item key="cell line">HT29</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402370"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402370"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402370"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402378"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402378"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402378"><item key="disease state">colon cancer</item><item key="cell line">Caco2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402417"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402417"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402417"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402420"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402420"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402420"><item key="disease state">breast cancer</item><item key="cell line">MCF7</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402520"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402520"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402520"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402526"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402526"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402526"><item key="disease state">breast cancer</item><item key="cell line">MDA-MB-468</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402529"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402529"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402529"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402533"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402533"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402533"><item key="disease state">pancreatic cancer</item><item key="cell line">MIA PaCa2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402560"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402560"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402560"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402652"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402652"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402652"><item key="disease state">erythroblastic leukemia</item><item key="cell line">K562</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM402655"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402655"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM402655"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate sensitive</item></item></item><item><item key="GSM40268"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM40268"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate resistant</item></item></item><item><item key="GSM40268"><item key="disease state">osteosarcoma</item><item key="cell line">Saos-2</item><item key="phenotype">methotrexate resistant</item></item></item></item><item key="id">3320</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">This SuperSeries is composed of the following subset Series:; GSE11440: Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance...</item><item key="pubmed_id">19732436</item><item key="geo_gse_id">E-GEOD-16648</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">42</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cadherin</item><item>cancer</item><item>colon</item><item>colon cancer</item><item>e-cadherin</item><item>leukemia</item><item>osteosarcoma</item><item>pancreatic cancer</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-by-array-of-human-cancer-2</item><item key="geo_id_plat">E-GEOD-16648_A-AFFY-44</item><item key="name">Transcription profiling by array of human cancer cell lines resistant to methotrexate</item><item key="created">Sep.12, 2014</item><item key="summary">This SuperSeries is composed of the following subset Series:; GSE11440: Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate in human HT29 colon cancer cells; GSE16066: Networking of differentially expressed genes in CaCo2 human colon cancer cells resistant to methotrexate; GSE16070: Networking of differentially expressed genes in human MCF7 breast cancer cells resistant to methotrexate; GSE16080: Networking of differentially expressed genes in human MDA-MB-468 breast cancer cells resistant to methotrexate; GSE16082: Networking of differentially expressed genes in human MIA PaCa2 pancreatic cancer cells resistant to methotrexate; GSE16085: Networking of differentially expressed genes in human K562 erythtoblastic leukemia cells resistant to methotrexate; GSE16089: Networking of differentially expressed genes in human Saos-2 osteosarcoma cells resistant to methotrexate Experiment Overall Design: Refer to individual Series</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16648</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16648/samples/</item></data></biogps>
